Myeong Jin Woo

ORCID: 0000-0002-3567-0616
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Urological Disorders and Treatments
  • Pediatric Urology and Nephrology Studies
  • Urinary Tract Infections Management
  • Abdominal Trauma and Injuries
  • Urinary and Genital Oncology Studies
  • Urinary Bladder and Prostate Research
  • Pelvic floor disorders treatments
  • Prostate Cancer Diagnosis and Treatment
  • Bladder and Urothelial Cancer Treatments
  • Trauma and Emergency Care Studies

Kyungpook National University
2015-2019

Purpose Currently, holmium laser enucleation of the prostate (HoLEP) and transurethral resection (TURP) are standard surgical procedures used to treat benign prostatic hyperplasia (BPH). Several recent studies have demonstrated that management BPH in patients with detrusor underactivity (DU) can effectively improve voiding symptoms, but comparative data on efficacy HoLEP TURP insufficient. Therefore, we compared short-term outcomes DU. Methods From January 2010 May 2015, 352 underwent or...

10.5213/inj.1732640.320 article EN cc-by-nc International Neurourology Journal 2017-03-28

The aim of this study was to assess the advantages robotic surgery, comparing perioperative and oncological outcomes between robot-assisted radical cystectomy (RARC) open (ORC).Between August 2008 May 2014, 112 cystectomies (42 RARCs 70 ORCs) were performed at a single academic institution following Institutional Review Board approval. Patient demographics, variables (e.g., complications), oncologic including metastasis-free survival (MFS), cancer-specific (CSS), overall (OS) reported using...

10.4111/icu.2016.57.4.260 article EN cc-by-nc Investigative and Clinical Urology 2016-01-01

Few studies have reported on breakthrough urinary tract infection (UTI) associated with the susceptibility of index UTI to prophylactic antibiotics in children primary vesicoureteral reflux (VUR) receiving continuous antibiotic prophylaxis (CAP). We assessed impact UTIs VUR CAP.We retrospectively reviewed medical records 81 who were diagnosed after febrile or symptomatic and subsequently received trimethoprim-sulfamethoxazole (TMP-SMX) as CAP between January 2010 December 2013. allocated a...

10.3346/jkms.2019.34.e156 article EN cc-by-nc Journal of Korean Medical Science 2019-01-01
Coming Soon ...